Cardinal Health stock remains in focus as healthcare distribution trends, service expansion, and market attention shape its ...

Cardinal Health, Inc. (NYSE:CAH) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with ...

Cardinal Healthcare Group is hoping to lead an initiative whereas the US government will offer 200 work visas for American providers to practice in Ukraine for up to 2 years. Goddard states “We’re on ...

Cardinal Health's Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds. Despite initial market overreaction to 2025 guidance, Cardinal Health's ...

May 2 (Reuters) - Cardinal Health (CAH.N), opens new tab raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly specialty drugs used to treat ...

Cardinal Health stock remains a buy due to strong pharmaceutical business growth and increased shareholder returns, despite short-term OptumRx and inflation challenges. Q4 and FY24 earnings exceeded ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min "We are adding more investments ...

Cardinal Health (NYSE:CAH) has released its 2026 Advanced Therapies Report. The report highlights a shift toward ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Cardinal Health CEO Jason Hollar ...

CLEVELAND, Oct 3 (Reuters) - Cardinal Health Inc , one of the nation's top drug wholesalers, expects its newer hospital supply and equipment businesses to grow faster and could benefit as the U.S.